

(ShareCast News) - Shire has acquired New York-based, privately-held Foresight Biotherapeutics for $300m. The deal gives Shire the global rights to FS...


-- Source link: (http://on.wsj.com/1E4jrJR) -- Note: Reuters has not verified this story and does not vouch for its accuracy